Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian D. Wakefield is active.

Publication


Featured researches published by Brian D. Wakefield.


Bioorganic & Medicinal Chemistry Letters | 2011

Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions

Irini Akritopoulou-Zanze; Brian D. Wakefield; Alan F. Gasiecki; Douglas M. Kalvin; Eric F. Johnson; Peter Kovar; Stevan W. Djuric

We report the synthesis and biological evaluation of 5-substituted indazoles as kinase inhibitors. The compounds were synthesized in a parallel synthesis fashion from readily available starting materials employing heterocycle forming and multicomponent reactions and were evaluated against a panel of kinase assays. Potent inhibitors were identified for Gsk3β, Rock2, and Egfr.


Bioorganic & Medicinal Chemistry Letters | 2011

Scaffold oriented synthesis. Part 3: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing [2+3] cycloadditions

Irini Akritopoulou-Zanze; Brian D. Wakefield; Alan F. Gasiecki; Douglas M. Kalvin; Eric F. Johnson; Peter Kovar; Stevan W. Djuric

We report the synthesis and biological evaluation of 5-substituted indazoles and amino indazoles as kinase inhibitors. The compounds were synthesized in a parallel synthesis fashion from readily available starting materials employing [2+3] cycloaddition reactions and were evaluated against a panel of kinase assays. Potent inhibitors were identified for numerous kinases such as Rock2, Gsk3β, Aurora2 and Jak2.


Bioorganic & Medicinal Chemistry Letters | 2008

Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.

Cory Michael Stiff; David R. Graber; Atli Thorarensen; Brian D. Wakefield; Keith R. Marotti; Earline P. Melchior; Michael T. Sweeney; Fusen Han; Douglas C. Rohrer; Gary E. Zurenko; Donna Lee Romero

The discovery and initial optimization of a novel anthranilic acid derived class of antibacterial agents has been described in a recent series of papers. This paper describes the discovery of 1-acylindazol-3-ols as a novel bioisostere of an anthranilic acid. The synthesis and structure-activity relationships of the indazol bioisosteres are described herein.


Archive | 2008

5-heteroaryl substituted indazoles as kinase inhibitors

Irini Akritopoulou-Zanze; Brian D. Wakefield; Helmut Mack; Sean Colm Turner; Alan F. Gasiecki; Vijaya Gracias; Kathy Sarris; Douglas M. Kalvin; Melissa J. Michmerhuizen; Qi Shuai; Jyoti R. Patel; Margaretha Henrica Maria Bakker; Nicole Teusch; Eric T Johnson; Peter Kovar; Stevan W. Djuric; Andrew J. Long; Anil Vasudevan; Adrian D. Hobson; John Moore Nigel; Lu Wang; Dawn M. George; Biqin Li; Kristine E. Frank


Archive | 2008

5-substituted indazoles as kinase inhibitors

Irini Akritopoulou-Zanze; Brian D. Wakefield; Helmut Mack; Sean Colm Turner; Alan F. Gasiecki; Vijaya Gracias; Kathy Sarris; Douglas M. Kalvin; Melissa J. Michmerhuizen; Qi Shuai; Jyoti R. Patel; Margaretha Henrica Maria Bakker; Nicole Teusch; Eric F. Johnson; Peter Kovar; Stevan W. Djuric; Andrew J. Long; Anil Vasudevan; Dawn M. George; Lu Wang; Biqin Li; N. St. John Moore; Adrian D. Hobson; Keith W. Woods; Julie M. Miyashiro; Steven L. Swann; Thomas D. Penning


Bioorganic & Medicinal Chemistry Letters | 2006

Discovery and initial development of a novel class of antibacterials: Inhibitors of Staphylococcus aureus transcription/translation

Scott D. Larsen; Matthew R. Hester; J. Craig Ruble; Gregg M. Kamilar; Donna L. Romero; Brian D. Wakefield; Earline P. Melchior; Michael T. Sweeney; Keith R. Marotti


Bioorganic & Medicinal Chemistry Letters | 2007

Preparation of novel anthranilic acids as antibacterial agents: extensive evaluation of structural and physical properties on antibacterial activity and human serum albumin affinity.

Atli Thorarensen; Jianke Li; Brian D. Wakefield; Donna L. Romero; Keith R. Marotti; Michael T. Sweeney; Gary E. Zurenko; Ronald W. Sarver


Bioorganic & Medicinal Chemistry Letters | 2007

Structure–activity relationships of bioisosteres of a carboxylic acid in a novel class of bacterial translation inhibitors

J. Craig Ruble; Brian D. Wakefield; Gregg M. Kamilar; Keith R. Marotti; Earline P. Melchior; Michael T. Sweeney; Gary E. Zurenko; Donna L. Romero


Bioorganic & Medicinal Chemistry Letters | 2007

Preparation of novel anthranilic acids as antibacterial agents. Extensive evaluation of alternative amide bioisosteres connecting the A- and the B-rings

Atli Thorarensen; Brian D. Wakefield; Donna L. Romero; Keith R. Marotti; Michael T. Sweeney; Gary E. Zurenko; Douglas C. Rohrer; Fusen Han; Garold L. Bryant


Archive | 2005

Nouveaux antagonistes de récepteur de mch

James P. Beck; Brian D. Wakefield; Frederic Laurent Cordier; Esteban Dominguez-Manzanares; Kevin Matthew Gardinier; Peter Michael Greenen; Kenneth Allen Savin

Collaboration


Dive into the Brian D. Wakefield's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric F. Johnson

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge